Note: Ingredients listed on restricted chemical lists
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2012-08-16
Product name
Compound Number
Chemical name
Janus kinase 3 (JAK3) inhibitor
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
DANGER
Section 2
SECTION 2: Hazards identification
Appearance: White or blue tablets
Signal word
DANGER
Hazard statements
May damage the unborn child. Suspected of damaging fertility.
Additional information
Short Term: Active ingredient may be harmful if swallowed. Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on lymphatic system, blood and blood forming organs Known Clinical Effects: Based on clinical trials in humans, possible adverse effects following exposure to this compound may include: nausea, headache, immune-mediated disorders, and hematological effects
EU Classification
EU Indication of danger: Toxic to Reproduction: Category 2 Toxic to Reproduction: Category 3 EU Hazard Symbols: EU Risk Phrases: R61 - May cause harm to the unborn child. R62 - Possible risk of impaired fertility. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
